Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02189525 · ClinicalTrials.gov registry record
Evaluation of Mild TBI in Collegiate Athletes
A clinical trial of Traumatic Brain Injury, sponsored by Banyan Biomarkers.
- Completed
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT02189525 is a study of Traumatic Brain Injury that has completed, run by Banyan Biomarkers. The registered enrollment target is 500 participants, above the 274-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (82% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02189525, a study of Traumatic Brain Injury, has completed, sponsored by Banyan Biomarkers.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate blood-based biomarkers before and after sports-induced concussion using neuroimaging and head impact sensor technology.
Conditions Studied
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2014-08 |
| Est. Completion | 2018-07-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02189525
The ClinicalTrials.gov registry entry for NCT02189525 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 274-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (82% higher). The listed sponsor is Banyan Biomarkers, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 0 interventions.
NCT02189525 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02189525 about?
NCT02189525 is a clinical study titled "Evaluation of Mild TBI in Collegiate Athletes". The purpose of this study is to evaluate blood-based biomarkers before and after sports-induced concussion using neuroimaging and head impact sensor technology.
What is the current status of trial NCT02189525?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2014-08. Estimated completion is 2018-07-25.
What conditions does trial NCT02189525 study?
This clinical trial studies the following conditions: Traumatic Brain Injury.
Who is sponsoring clinical trial NCT02189525?
This trial is sponsored by Banyan Biomarkers, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02189525 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
A Study to Evaluate the SENSE Device's Ability to Detect TBI
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.